Retinopathy of prematurity: Recommendations for screening

Paediatrics and Child Health

Volumn 15, Issue 10, 2010, Pages 667-

  Jefferies, A L ^b   Hilliard, Robert I ^a   Peliowski Davidovich, Abraham ^c   Sorokan, S Todd ^d   Whyte, Hilary E A ^a   Whyte, Robin K ^e  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c ROYAL ALEXANDRA HOSPITAL   (Canada)

^d IWK Health Centre ^*

^e IWK HEALTH CENTRE   (Canada)

Author keywords

Laser therapy; Preterm infant; Retinopathy of prematurity; Screening

Indexed keywords

ANESTHETIC AGENT; INOTROPIC AGENT;

ABLATION THERAPY; AGE; ARTIFICIAL VENTILATION; BIRTH WEIGHT; CHILD CARE; CRYOTHERAPY; DISEASE CLASSIFICATION; DOCTOR PATIENT RELATION; EYE EXAMINATION; FOLLOW UP; GESTATIONAL AGE; HOSPITAL DISCHARGE; HUMAN; HYPOTENSION; INFANT; LASER COAGULATION; MEDICAL SOCIETY; NEWBORN SCREENING; OXYGEN THERAPY; POSTMENSTRUAL AGE; PRACTICE GUIDELINE; PREMATURITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT DISEASE; RETINA DETACHMENT; RETINAL ABLATIVE THERAPY; RETROLENTAL FIBROPLASIA; REVIEW; VISUAL ACUITY; WEIGHT GAIN;

EID: 80053940116     PISSN: 12057088     EISSN: None     Source Type: Journal    
DOI: 10.1093/pch/15.10.667     Document Type: Review

References (20)

1. Schmidt B, Asztalos EV, Roberts RS, Robertson CM, Sauve RS, Whitfield MF; Trial of Indomethacin Prophylaxis in Preterms (TIPP) Investigators. Impact of bronchopulmonary dysplasia, brain injury and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: Results from the trial of indomethacin prophylaxis in preterms. JAMA 2003;289:1124-9. (Pubitemid 37430326)
2. Ng EY, Connolly BP, McNamara JA, Regillo CD, Vander JF, Tasman W. A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: Part 1. Visual function and structural outcome. Ophthalmology 2002;109:928-34. (Pubitemid 34465227)
3. Canadian Paediatric Society, Fetus and Newborn Committee [Principal author: M Vincer]. Retinopathy of prematurity: Recommendations for screening. Paediatr Child Health 1998;3:197.
4. American Academy of Pediatrics, Section on Ophthalmology; American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus. Screening examination of premature infants for retinopathy of prematurity. Pediatrics 2006;117:572-6.
5. Royal College of Paediatrics and Child Health. Guideline for the Screening and Treatment of Retinopathy of Prematurity. 〈www.rcpch.ac. uk〉 (Accessed on September 9, 2010).
6. International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol 2005;123:991-9.
7. Canadian Paediatric Society, Fetus and Newborn Committee [Principal author: M Vincer]. Retinopathy of prematurity: A systematic review of the literature. Paediatr Child Health 1998;3:173-9.
8. Ho SF, Mathew MR, Wykes W, Lavy T, Marshall T. Retinopathy of prematurity: An optimum screening strategy. J AAPOS 2005;9:584-8. (Pubitemid 43097389)
9. Haines L, Fielder AR, Baker H, Wilkinson AR. UK population based study of severe retinopathy of prematurity: Screening, treatment and outcome. Arch Dis Child Fetal Neonatal Ed 2005;90:F240-4. (Pubitemid 40593454)
10. Shah VA, Yeo CL, Ling YL, Ho LY. Incidence, risk factors of retinopathy of prematurity among very low birth weight infants in Singapore. Ann Acad Med Singapore 2005;34:169-78. (Pubitemid 40545454)
11. Ahmed MA, Duncan M, Kent A; NICUS Group. Incidence of retinopathy of prematurity requiring treatment in infants born greater than 30 weeks' gestation and with a birthweight greater than 1250 g from 1998 to 2002: A regional study. J Paediatr Child Health 2006;42:337-40. (Pubitemid 43823334)
12. Slidsborg C, Olesen HB, Jensen PK, et al. Treatment for retinopathy of prematurity in Denmark in a ten-year period (1996-2005): Is the incidence increasing? Pediatrics 2008;121:97-105.
13. Lee SK, Normand C, McMillan D, Ohlsson A, Vincer M, Lyons C; Canadian Neonatal Network. Evidence for changing guidelines for routine screening for retinopathy of prematurity. Arch Pediatr Adolesc Med 2001;155:387-95. (Pubitemid 32199188)
14. Ells A, Hicks M, Fielden M, Ingram A. Severe retinopathy of prematurity: Longitudinal observation of disease and screening implications. Eye 2005;19:138-44. (Pubitemid 40309498)
15. Schiariti V, Matsuba C, Houbé JS, Synnes AR. Severe retinopathy of prematurity and visual outcomes in British Columbia: A 10-year analysis. J Perinatol 2008;28:566-72.
16. Reynolds JD, Dobson V, Quinn GE, et al CRYO-ROP and LIGHT-ROP Cooperative Study Groups. Evidence-based screening criteria for retinopathy of prematurity: Natural history data from the CRYO-ROP and LIGHT-ROP studies. Arch Ophthalmol 2002;120:1470-6. (Pubitemid 36406421)
17. Hutchinson AK, Saunders RA, O'Neil JW, Lovering A, Wilson ME. Timing of initial screening examinations for retinopathy of prematurity. Arch Ophthalmol 1998;116:608-12. (Pubitemid 28414575)
18. Misra A, Heckford E, Curley A, Allen L. Do current retinopathy of prematurity screening guidelines miss the early development of pre-threshold type 1 ROP in small for gestational age neonates? Eye 2008;22:825-9. (Pubitemid 351850520)
19. Hellström A, Hård A, Engström E, et al. Early weight gain predicts retinopathy in preterm infants: New, simple, efficient approach to screening. Pediatrics 2009;123:e638-45.
20. Good WV; Early Treatment for Retinopathy of Prematurity Cooperative Group. Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc 2004;102:233-48.